-
LRRK2 Function in Immunity
… that side effects (if any) of such treatment on the immune system can be avoided. The role of wild-type and mutant … inhibitors on immune cell function, will be tested in model systems. Hypothesis: Due to the increased enzymatic activity … manifest itself in changes in the ability of the immune system to respond to infection. We further hypothesize that …
-
Nicotinic receptor agonists and L-dopa-induced dyskinesias
… activates all nAChRs in the peripheral and central nervous system. Interestingly, the nAChRs in the brain are distinct from those in the peripheral nervous system. We therefore propose to test the effect of nAChR … brain nAChRs and not those in the peripheral nervous system. The results will allow for the development of …
-
Is Parkinson’s Disease Just a Movement Disorder?
June 21, 2012
… is pointing to the fact that Parkinson’s may involve other systems in the body, beyond the central nervous system. “I am amazed to think how our vision of PD continues … the entire brain itself to include the colon and other systems. We should have no fear to change our perspectives …
-
Serotonin and Sleep Disordered Breathing in Parkinson Disease
… as obstructive sleep apnea) in Parkinson’s disease. Brain systems using the neurotransmitter serotonin are involved in … of breathing during sleep. Degeneration of serotonin systems occurs in Parkinson’s disease. We will determine if loss of serotonin brain systems underlies sleep disordered breathing in Parkinson …
-
Targeting of 5-HT1A and 5-HT2A Receptors Against Levodopa-induced Dyskinesia
… sub-therapeutic doses of drugs that targeted these receptor systems to reduce levodopa-induced dyskinesias without … validate the strategy of targeting more than one receptor system to get anti-dyskinetic benefits. Further studies are … “Pharmacological modulation of Serotonin and Norepinephrine systems as therapy for improved treatment in Parkinson’s …
-
Immunotherapy with Alpha-synuclein Specific Antibody
… will also enable us to evaluate the role of the immune system and minimize potential safety issues. Optimized … interaction between the antibody and the patient’s immune system. We will also learn about the dynamics between … than the original antibody to be destroyed by the immune system. This improvement made the new antibody eligible for …